MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Metacrine, Inc. (NASDAQ: MTCR)
Organization & Developments: Metacrine
Parents
Metacrine, Inc. (NASDAQ: MTCR)
Children
2020: Biotech Analysis Central Preview Series: Metacrine Inc.
2022: Metacrine: Potential Play On A Higher Bid_ seekingalpha.com
Clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and GI diseases.
Jumps
Finance & Acquisitions: Metacrine
Key People: Metacrine